ACE and Stroke: Finally, the use of the ACE inhibitor ramipril in the heart outcomes prevention evaluation (HOPE) trial resulted in areduction in all-cause and cardiovascular mortality as well as cardiovascular events, including myocardial infarction and stroke [28].